# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-020375
Filing Date
2021-04-23
Accepted
2021-04-23 16:50:53
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | adpt-defa14a_20210611.htm | DEFA14A | 27601
2 | GRAPHIC | gbqh1oxadoko000002.jpg | GRAPHIC | 251499
3 | GRAPHIC | gbqh1oxadoko000001.jpg | GRAPHIC | 634656
| Complete submission text file | 0001564590-21-020375.txt |  | 1249309

Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38957 | Film No.: 21850479
SIC: 2836 Biological Products, (No Diagnostic Substances)